Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs

Iranian Biomedical Journal

Volumn 12, Issue 2, 2008, Pages 59-66

  Fotouhi, Fatemeh ^a   Soleimanjahi, Hoorieh ^a   Roostaee, Mohammad Hasan ^a   Asl, Abdolhossein Dalimi ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Baculovirus; Herpes simplex virus type 2 (HSV 2); Insect cells; Protein expression; Subunit vaccine

Indexed keywords

BACULOVIRUS VECTOR; GLYCOPROTEIN D; PROTEIN SUBUNIT; VIRUS DNA;

ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CLONING VECTOR; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; DNA TEMPLATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENITAL HERPES; GUINEA PIG; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INSECT CELL; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; RESTRICTION MAPPING; SERODIAGNOSIS; WESTERN BLOTTING;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELLS, CULTURED; CLONING, MOLECULAR; FEMALE; GUINEA PIGS; HELA CELLS; HERPES GENITALIS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 2, HUMAN; HUMANS; MALE; SPODOPTERA; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS;

CAVIA; HERPES; HEXAPODA; HUMAN HERPESVIRUS 2; MAMMALIA; SIMPLEXVIRUS;

EID: 45349102135     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wachsman, M., Kulka, M., Smith, C.C. and Aurelian, L. (2001) A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs. Vaccine 19: 1879-1890.
2. Aurelian, L. (2004) Herpes simplex virus type 2 vaccines: new ground for optimism? Clin. Diag. Lab. Immunol. 11 (3): 437-445.
3. Milligan, G.N. and Bernstein, D.I. (1995) Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 206: 234-241.
4. Bernstein, D.I. and Stanberry, L.R. (1999) Herpes simplex virus vaccines. Vaccine 17: 1681-1689.
5. Bourne, N., Bravo, F.J., Francotte, M., Bernstein, D.I., Myers, M.G., Slaoui, M. and Stanberry, L.R. (2003) Herpes simplex virus type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 and HSV-2 disease in guinea pigs. J. Infect. Dis. 187: 542-549.
6. Lee, H.H., Cha, S.C., Jang, D.J., Lee, J.K., Choo, D.W., Kim, Y.S., Uh, H.S. and Kim, S.W. (2002) Immunization with combined HSV-2 glycoproteins B2-D2 gene DNAs: protection against lethal intravaginal challenges in mice. Virus Genes 25:179-188.
7. Baghian, A., Choujenko, V.N., D'auvergne, O., Newman, M.J., Baghian, S. and Kousoulas, K.G. (2002) Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunization with herpes simplex virus type-1 genes specifying glycoprotein B and D. J. Med. Microbiol. 51: 350-357.
8. Straus, S.E., Savarese, B., Tigges, M., Freifeld, A.G., Krause, P.R., Margolis, D.M., Meier, J.L., Paar, D.P., Adair, S.F., Dina, D., Dekker, C. and Burke, R.L. (1993) Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by a recombinant glycoprotein D vaccine. J. Infect. Dis. 167: 1045-1052.
9. Langenberg, A.G., Burke, R.L., Adair, S.F., Sekulovich, R., Tigges, M., Dekker, C.L. and Corey, L. (1995) A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity. Ann. Intern. Med. 122: 889-898.
10. Ghiasi, H., Kiawar, R., Nesburn, A.B., Slanina, S. and Wechsler, S.L. (1994) Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virol. 68: 2118-2126.
11. Landolfi, V., Zarley, C.D., Abramovitz, A.S., Figeroa, N., Wu, S.L., Blasiak, M., Ishizaka, S.T. and Mishkin, E.M. (1993) Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge. Vaccine 11: 407-414.
12. Burke, R.L. (1993) HSV vaccine development. In: The Herpesviruses, (B. Roizman and C. Lopez eds.), Raven Press, New York, USA. pp. 367-380.
13. Nicola, A.V., Willis, S.H., Naidoo, N.N., Eisenberg, R.J. and Cohen, G.H. (1996) Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J. Virol. 70: 3815-3822.
14. Kim, T.K. and Yeo, S.G. (2003) Expression of VP2 protein of infectious bursal disease virus detected in Korea. Virus Genes 27 (1): 75-81.
15. Anderson, D., Harris, R., Polayers, D., Ciccarone, V., Donahue, R., Gerald, G., Jessee, J. and Luckow, V. (1995) Rapid generation of recombinant baculovirus and expression of foreign genes using the BAC-to-BAC Baculovirus Expression System. Focus 17 (2): 53-58.
16. Luckow, V.A., Lee, S.C., Barry, G.F. and Olins, P.O. (1993) Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 67 (8): 4566-4579.
17. Fotouhi, F., Roostaee, M.H., Soleimanjahi, H., Haqshenas, G.R. and Jamalidoust, M. (2005) Construction of an eukaryotic expression vector encoding herpes simplex virus type 2 glycoprotein D and in vitro expression of the desired protein. Arch. Razi. Ins. 59: 1-11.
18. Sambrook, J. and Russell, D.W. (2001) Molecular cloning: A laboratory manual. (3rd ed). Cold Spring Harbor, N.Y., USA.
19. Soleimanjahi, H., Roostaee, M.H., Rasaee, M.J., Mahboudi, F., Kazemnejad, A., Bamdad, T. and Zandi, K. (2006) The effect of DNA priming-protein boosting in enhancing the humoral immunity and protecting the mice against lethal HSV infections. FEMS Immunol. Med. Microbiol. 46 (1): 100-106.
20. McClements, W.L., Armestrong, M.E., Keys, R.D. and Liu, M.A. (1996) Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA 93: 11414-11420.
21. Mester, J.C., Twomey, T.A., Tepe, E.T. and Bernstein, D.I. (2000) Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C. Vaccine 18: 875-883.
22. Bourne, N., Milligan, G.N., Stanberry, L.R., Stegall, R. and Pyles, R.B. (2005) Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. J. Infect. Dis. 192: 2117-2123.
23. Nicola, A.V., Ponce de Leon, M., Xu, R., Hou, W., Whitebeck, J.C., Krummenacher, C., Montgomery, R.I., Spear, P.G., Eisenberg, R.J. and Cohen, G.H. (1998) Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J. Virol. 72: 3595-3601.
24. Li, B., Wu, H.Y., Qian, X.P., Li, Y. and Chen, W.F. (2003) Expression, purification and serological analysis of hepatocellular carcinoma associated antigen HCA587 in insect cells. World J. Gastroenterol. 9 (4): 678-682.
25. Roy, P., Mikhailov, M. and Bishop, D. (1997) Baculovirus multigene expression vectors and their use for understanding the assembly process of architecturally complex virus particles. Gene 190: 119-129.